Choice of drugs for heparin-induced thrombocytopenia

Medical Letter on Drugs and Therapeutics

Volumn 54, Issue 1391, 2012, Pages 43-44

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; DANAPAROID; FONDAPARINUX; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; WARFARIN;

ARTICLE; BLEEDING; DIAGNOSTIC ACCURACY; DRUG WITHDRAWAL; ENZYME IMMUNOASSAY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOASSAY; PATHOGENESIS; SCORING SYSTEM; SEROTONIN RELEASE ASSAY; THROMBOCYTOPENIA; THROMBOSIS;

EID: 84868603555     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. TE Warkentin. How I diagnose and manage HIT. Hematology Am Soc Hematol Educ Program 2011; 2011:143.
2. A Cuker and DB Cines. How I treat heparin-induced thrombocytopenia. Blood 2012; 119:2209.
3. L Linkins et al. Treatment and prevention of heparin-induced thrombocytopenia. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence- based clinical practice guidelines. Chest 2012; 141 (2 suppl):e495S.
4. A Cuker et al. The HIT Expert Probability (HEP) Score: a novel pretest probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost 2010; 8:2642.
5. MA Crowther et al. The 4Ts scoring system for heparininduced thrombocytopenia in medical-surgical intensive care unit patients. J Crit Care 2010; 25:287.
6. Argatroban for treatment of heparin-induced thrombocytopenia. Med Lett Drugs Ther 2001; 43:11.
7. BH Chong et al. Prospective randomized open-label comparison of danaparoid with dextran 70 in the treatment of heparininduced thrombocytopaenia with thrombosis: a clinical outcome study. Thromb Haemost 2001; 86:1170.
8. N Lubenow et al. Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s. Thromb Res 2006; 117:507.
9. TE Warkentin et al. Fondaparinux treatment of acute heparininduced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series. J Thromb Haemost 2011; 9:2389.
10. TE Warkentin. Agents for the treatment of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am 2010; 24: 755.
11. TE Warkentin. HIT paradigms and paradoxes. J Thromb Haemost 2011; 9(suppl1):105.
12. Antithrombotic drugs. Treat Guidel Med Lett 2011; 9: 61.
13. TE Warkentin. Fondaparinux: does it cause HIT? Can it treat HIT? Expert Rev Hematol 2010; 3:567.